This seminar will report on the findings of the CoLAB qualitative study which aimed to examine the multiple social, material and temporal effects of extended-release buprenorphine depot (BUP-XR) treatment in clients’ lives, among a group of participants receiving BUP-XR in Australia, and consider the situated potentials of these new opioid agonist treatment technologies. In particular, […]

Prenatal drug exposure is one of the fastest growing public health problems in the world. A great deal of attention is focused on treating the infant's withdrawal after birth and reducing duration of hospitalisation but emerging evidence shows that later problems, such as increased risk of death, disability and intra-generational disadvantage. The focus on identifying, […]

There is increasing recognition of the value of the AOD peer workforce. However, less is known about AOD workers who have lived and living experience of AOD use, but do not work in designated peer roles. This presentation provides an overview of the demographic and professional profile of AOD workers with lived and living experience, […]

Respond sensitively and effectively to people who have experienced trauma  A large proportion of people in alcohol and other drug treatment have experienced trauma as a child or adult. In this interactive online workshop, learn how to deliver alcohol and other drug treatment in a trauma informed way to improve outcomes. You will also learn […]

About this event The seminar will give an overview of a study that investigates the impact of opioid agonist treatment (OAT) on hospitalisations for injecting-related diseases using large administrative health data. The sample includes people who have been prescribed OAT in New South Wales from 2001 to 2017. We compared the incidence rates of hospitalisations […]